Skip to main content
. 2024 Nov 6;8(4):rkae132. doi: 10.1093/rap/rkae132

Table 1.

Disease activity assessment and responder group 1, responder group 2 and non-responder group populations

Total (N = 130), n (%)
LDA (CDAI > 2.8–10) 42 (32.3)
HDA (CDAI > 22) 13 (10.0)
MDA (CDAI > 10–22) 41 (31.5)
CR (CDAI <= 2.8) 34 (26.2)
Responders
1. CR 34 (26.2)
2. CR + LDA 76 (58.5)
Non-responders
MDA + HDA 54 (41.5)